| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfd7bf80e4e2aa08ce30f3cabc8c71b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-18 |
| filingDate |
2012-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09a6d3a8e1117f0acbe86083099ec038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37b61352b367e4f26e52f65004636fe0 |
| publicationDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2624427-T3 |
| titleOfInvention |
Treatment of diseases and disorders related to the activity of transducin beta-type protein 1 (TBL 1), including myeloproliferative neoplasia and chronic myeloid leukemia |
| abstract |
A therapeutically effective amount of an agent that alters the interaction of TBL1 with a coactivating molecule for use in the treatment and / or prevention of myeloproliferative neoplasia or chronic myeloid leukemia, said agent having the formula: ** Formula ** or a pharmaceutically salt acceptable of it. |
| priorityDate |
2011-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |